PR Newswire Clinical TrialsOriginal article
Pulnovo Medical Announces First Two U.S. Patients Enrolled in PULSE-LHD IDE Clinical Trial of Pulmonary Artery Denervation in Treating Pulmonary Hypertension Associated with Left Heart Disease
Trial StartPulmonary Artery DenervationPositive
AI Analysis
Summary
Pulnovo Medical announced enrollment of the first two U.S. patients in its PULSE-LHD IDE clinical trial evaluating pulmonary artery denervation for treating pulmonary hypertension associated with left heart disease.
Clinical Trial Data
Patients
2
Outcome Details
First two U.S. patients enrolled in PULSE-LHD IDE clinical trial
Importance:3/10
Sentiment:
0.30
Clinical TrialMedical DevicePulmonary HypertensionHeart FailureFDAIDE
Read the original article
Published by PR Newswire Clinical Trials on August 24, 2026 3:05 AM